Inhibition of glycolysis by a novel EGFR/HER2 inhibitor KU004 suppresses the growth of HER2+ cancer. [electronic resource]
Producer: 20171010Description: 211-221 p. digitalISSN:- 1090-2422
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Breast Neoplasms -- metabolism
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cyclic P-Oxides -- pharmacology
- Glycolysis -- drug effects
- Humans
- Phosphatidylinositol 3-Kinases -- metabolism
- Quinazolines -- pharmacology
- Receptor, ErbB-2 -- metabolism
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.